Detection of Macrolide-Resistant Streptococcus pneumoniae Genes and Its Clinical Outcomes in a Tertiary Teaching

Wan Norliyana Wan Mahmud1, Siti Asma' Hassan2, Zaidah Abd Rahman2

  • 1Hospital Kemaman, Terengganu, Malaysia.

Abstract

Insights

Drug-resistant Streptococcus pneumoniae poses a significant global health threat. This study found macrolide resistance in pneumococcal infections, primarily linked to the mef(A) gene, without impacting mortality or complications.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Streptococcus pneumoniae causes significant global mortality and morbidity.
  • Increasing antimicrobial resistance, especially to beta-lactams and macrolides, complicates pneumococcal infection treatment.
  • This study investigated drug resistance and macrolide-resistant genes in pneumococcal infections at Hospital Universiti Sains Malaysia.

Purpose of the Study:

  • To determine the drug resistance rates of Streptococcus pneumoniae isolates.
  • To assess the prevalence of macrolide-resistant genes in these isolates.
  • To review the clinical complications associated with pneumococcal infections.

Main Methods:

  • Descriptive cross-sectional study design.
  • Antimicrobial susceptibility testing using E-test strips for S. pneumoniae isolates.
  • Polymerase chain reaction (PCR) to detect macrolide-resistant determinants (mef(A) and erm(B)).

Main Results:

  • Penicillin resistance was 7.1% and erythromycin resistance was 26.5%.
  • The mef(A) gene was the most prevalent macrolide resistance determinant (50.4%), followed by erm(B) (20%).
  • No significant association was found between macrolide resistance determinants and mortality or specific complications.

Conclusions:

  • The mef(A) gene is the primary driver of macrolide resistance in S. pneumoniae isolates studied.
  • Erythromycin-resistant isolates frequently carried mef(A), erm(B), or both.
  • Understanding resistance patterns is crucial for effective pneumococcal infection management.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90